深天馬A(000050.SZ)A股定增募資不超73億元獲中國航空工業集團批覆
格隆匯11月28日丨深天馬A(000050.SZ)公佈,公司於近日收到中國航空技術國際控股有限公司轉發的中國航空工業集團有限公司《關於天馬微電子股份有限公司非公開發行A股股份有關問題的批覆》(航空資本〔2019〕947號),批覆主要內容如下:
“根據《上市公司國有股權監督管理辦法》(國資委財政部證監會令第36號)等有關規定,經研究,現就天馬微電子股份有限公司本次非公開發行A股股份涉及的國有股權管理有關問題批覆如下:
原則同意深天馬本次非公開發行不超過40962.461萬股A股股份、募集資金總額不超過73億元的總體方案。”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.